Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model.
Martins, Larissa M S; Perez, Malena M; Pereira, Camila A; Costa, Frederico R C; Dias, Murilo S; Tostes, Rita C; Ramos, Simone G; de Zoete, Marcel R; Ryffel, Bernhard; Silva, João S; Carlos, Daniela.
; 2018 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-29722014
Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection.
Disruption of Epithelial HDAC3 in Intestine Prevents Diet-Induced Obesity in Mice.
Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.
Augmented Responses to Ozone in Obese Mice Require IL-17A and Gastrin-Releasing Peptide.
Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis.
Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production.
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.
Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch.
APMAP interacts with lysyl oxidase-like proteins, and disruption of <i>Apmap</i> leads to beneficial visceral adipose tissue expansion.